DM-2 progresses with hyperinsulinemia secondary to hyperglycemia and resistance develops over time due to the continuous stimulation of insulin receptors, especially in patients with a BMI >30 [24,25]. This evidence concerns the gene INSR and myotonic dystrophy type 2.